Printer Friendly

VIRAL TESTING SYSTEMS ANNOUNCES SALE OF ITS TELEPHONE BUSINESS

 HOUSTON, July 1 /PRNewswire/ -- Viral Testing Systems Corporation (AMEX: VTS) today announced the sale of its telephone subsidiary, TeleConcepts, Inc. of Connecticut, which will now enable VTS to focus entirely on the medical diagnostics business. Under terms of the sale, VTS received cash, short term notes and convertible preferred stock from the purchaser, Ampac International Corporation, a privately held company. No gain or loss is expected to be recognized as a result of the sale.
 Paul Montle, president and chief executive officer of VTS, said, "Since Travis Partners acquired control of the company only eighteen short months ago, much has been accomplished. With the sale of TeleConcepts we have strengthened our financial position, and are now 100 percent in the medical diagnostics business. We are an entirely different company focused on the major and rapidly growing medical testing market."
 VTS is the exclusive North and South America distributor of FLUOROGNOST HIV-1 IFA, the only FDA approved test that can both screen and confirm for HIV and obtain results within 90 minutes. The company has also been negotiating to acquire a medical consumer products distributor.
 -0- 7/1/93
 /CONTACT: Holly Vaughan, investor relations of Viral Testing Systems, 713-228-4633/
 (VTS)


CO: Viral Testing Systems Corporation; TeleConcepts, Inc.; Ampac
 International Corporation ST: Texas, Connecticut IN: HEA TLS SU:


WB-MG -- NY050 -- 7706 07/01/93 11:59 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 1, 1993
Words:225
Previous Article:GRUPO SIMEC, S.A. DE C.V LISTS ON THE AMERICAN STOCK EXCHANGE; SECOND MEXICAN COMPANY TO LIST IN THE U.S. IN 1993
Next Article:UNITED AIRLINES AND TRANS WORLD EXPRESS, INC. ANNOUNCE MARKETING AGREEMENT
Topics:


Related Articles
TELECONCEPTS RECEIVES FIRM COMMITMENTS FOR EQUITY PLACEMENT IN EXCESS OF MINIMUM REQUIRED FOR MERGER WITH THERMASCAN, INC.
TELECONCEPTS SAYS AIDS TEST MAY IDENTIFY NEW HIV STRAIN
VIRAL TESTING SYSTEMS' JANUARY SALES OF HIV TEST BETTER THAN EXPECTED
TRAVIS PARTNERS EXERCISES VIRAL TESTING SYSTEMS CORPORATION WARRANTS
MERIDIAN DIAGNOSTICS SELLS CULTURESET TO VAI DIAGNOSTICS, INC.
FDA ADVISORY COMMITTEE RECOMMENDS APPROVAL FOR ROCHE'S AMPLICOR HIV MONITOR TEST
FDA ADVISORY COMMITTEE RECOMMENDS APPROVAL FOR ROCHE'S AMPLICOR HIV MONITOR TEST
AMPLICOR HIV-1 MONITOR(TM) TEST FIRST TO RECEIVE FDA APPROVAL FOR MARKETING
US Patent Issued to Visible Genetics Inc. for Combination HIV Viral Load and Genotyping Test.
Bayer will buy Visible Genetics Inc. for USD $61.4 million. (News Briefs).

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters